Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients

Moroi, 1980, Autoantibody to centromere (kinetochore) in scleroderma sera, Proc Natl Acad Sci, 77, 1627, 10.1073/pnas.77.3.1627 Fritzler, 1980, The CREST syndrome: a distinct serologic entity with anticentromere antibodes, Am J Med, 69, 520, 10.1016/0002-9343(80)90462-3 Earnshaw, 1985, Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma, Chromosoma, 91, 313, 10.1007/BF00328227 Palmer, 1991, Purification of the centromere-specific protein CENP-A and demonstration that it is a distinctive histone, Proc Natl Acad Sci, 88, 3734, 10.1073/pnas.88.9.3734 Yoda, 1992, A human centromere protein, CENP-B, has a DNA binding domain containing four potential a helices at the NH2 terminus, which is separable from dimerzing activity, J Cell Biol, 119, 1413, 10.1083/jcb.119.6.1413 Sugimoto, 1992, Anti-helix-loop-helix domain antibodies: discovery of autoantibodies that inhibit DNA binding activity of human centromere protein B (CENP-B), J Biochem, 111, 478, 10.1093/oxfordjournals.jbchem.a123783 Page, 1995, Further evidence that CENP-C is a necessary component of active centromeres: studies of a dice (X;15) with simultaneous immunofluorescent and FISH, Hum Mil Genet, 4, 289294 Hayashi, 2000, Differences in specificities of anti-centromere sera for monomeric and dimeric C-terminal peptide of human centromere protein C, Int Immunol, 12, 1431, 10.1093/intimm/12.10.1431 Makinen, 1983, Anticentromere antibodies in primary biliary cirrhosis, Arthritis Rheum, 26, 914, 10.1002/art.1780260714 Tojo, 2002, Clinicolaboratory characteristics of patients with primary bililarry cirrhosis associated with CREST symptoms, Hepatol Res, 22, 187, 10.1016/S1386-6346(01)00138-3 Nakamura, 2007, Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis, Hepatology, 45, 118, 10.1002/hep.21472 Earnshaw, 1987, Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B, Proc Natl Acad Sci U S A, 84, 4979, 10.1073/pnas.84.14.4979 Rothfield, 1987, Detection of anticentromere antibodies using cloned autoantigen CENP-B, Arthritis Rheum, 30, 1416, 10.1002/art.1780301214 Sun, 1996, Detection of anticentromere antibodies using recombinant human CENP-A protein, Arthritis Rheum, 39, 863, 10.1002/art.1780390520 Russo, 2000, Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis, J Rheumatol, 27, 142 Hoshino, 2008, Comparison of ELISA with CENP-A and CENP-B for the detection of anti-centromere antibody, Clin Exp Rheumatol, 26, 505 Muro, 2000, Autoepitopes on autoantigen centromere protein-A (CENP-A) are restricted to N-terminal region, which has no homology with histone H3, Clin Exp Immunol, 120, 218, 10.1046/j.1365-2249.2000.01189.x Pillemer, 2004, Centromere protein C is a target autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La, J Rheumatol, 31, 1121 Himoto, 2010, Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody, Hepatol Res, 40, 786, 10.1111/j.1872-034X.2010.00684.x Himoto, 2009, Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody, Dig Dis Sci, 54, 360, 10.1007/s10620-008-0359-y Gelber, 2006, Distinct recognition of antibodies to centromere proteins in primary Sjögren's syndrome compared with limited scleroderma, Ann Rheum Dis, 65, 1028, 10.1136/ard.2005.046003 Alvarez, 1999, International autoimmune hepatitis group report: review of criteria for a diagnosis of autoimmune hepatitis, J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9 Degott, 1999, Histopathological study of primary billiary cirrhosis and the effect of ursodeoxycholic acid treatment on histological progression, Hepatology, 29, 1007, 10.1002/hep.510290444 Muro, 1992, The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen, J Dermatol, 19, 584, 10.1111/j.1346-8138.1992.tb03734.x Sugimoto, 1998, Epitope mapping of human centromere autoantigen centromere protein C (CENP-C); heterogeneity of anti-CENP-C response in rheumatic disease, J Rheumatol, 25, 474 Saito, 2009, CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis, J Rheumatol, 36, 781, 10.3899/jrheum.080726 Watanabe, 2004, Anti-DFS70 antibodies in 597 healthy hospital workers, Arthritis Rheum, 50, 892, 10.1002/art.20096 Knodell, 1981, Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis, Hepatology, 1, 431, 10.1002/hep.1840010511 Scheuer, 1967, Primary biliary cirrhosis, Proc R Soc Med, 60, 1257 Tomita, 2011, Serum immunoglobulin A concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage, Dig Dis Sci, 56, 3648, 10.1007/s10620-011-1771-2 Kremer, 1988, Protein responsible for anticentromere activity found in the sera of patients with CREST-associated Raunaud's phenomenon, Clin Exp Immunol, 72, 465 Bogdanos, 2001, Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences, Liver, 21, 225, 10.1034/j.1600-0676.2001.021004225.x Shoji, 1992, Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis, Intern Med, 31, 1348, 10.2169/internalmedicine.31.1348